Abstract
Background Counterfeit medicines (CFMs) are a global problem with significant and well-documented consequences for global health and patient safety, including drug resistance and patient deaths. Reports of counterfeit pharmaceuticals in Africa indicate a wide variety of detrimental effects.
Objectives The aim of the present study was to assess the extent, awareness and attitude of public in Sudan towards CFMs.
Methods A cross-sectional study was conducted applying pretested and structured questionnaire. The awareness and attitude were assessed statistically and the association between those and different demographic characteristics was calculated using Fisher exact test and Spearman correlation.
Results A total of 386 participants have enrolled in the study. The majority of the respondents (58%) were found to be aware about the term CFMs with social media mentioned to be the main source. 73% of the respondents considered CFMs of worse quality suggesting getting the medicine from a trustworthy pharmacist in order to avoid buying CFMs. 56% reported their ability to distinguish CFMs from the side effects rather than the package and cost. Education was suggested by 82% of the respondents to have vital role in combating CFMs spread through workshops and campaigns. 68% of the participants were found to have a fair awareness about CFMs. Furthermore, 80% of them showed a good attitude toward CFMs
Conclusion Current literature includes gaps in knowledge and attitude towards CFMs. Therefore attention and concentrated efforts are required on the part of the government, drug manufacturers and health care providers’ especially pharmaceutical analysts to ensure that only drugs of acceptable quality reach the patient.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research is fully funded by the Ministry of Higher Education and Scientific Research, Sudan
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Research Committee, Faculty of Pharmacy, University of Khartoum
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All dataset supporting this article is available within the article and its supplementary files.
